Bazedoxifene approval date japan?

When was bazedoxifene approved in Japan?

Bazedoxifene (marketed in Japan as Vivena) received approval in Japan on May 16, 2014 [1].

What is bazedoxifene used for in Japan?

In Japan, bazedoxifene is used for osteoporosis in postmenopausal women [1].

What brand names and identifiers are used in Japan?

In Japan, bazedoxifene is associated with the brand name Vivena [1].

Is this the same as launch or reimbursement timing?

The date above is the approval date. The provided source does not give a separate launch, pricing, or reimbursement date.

Source

1